Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Subcutaneous Implantable Defibrillator Market size was valued at USD 9.02 billion in 2024 and is set to exceed USD 15.79 billion by 2037, registering over 4.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of subcutaneous implantable defibrillator is evaluated at USD 9.36 billion.
Factors leading to the prevalence of cardiovascular diseases such as increasing geriatric population, unhealthy lifestyle of people, alcohol consumption, smoking, and others, are anticipated to create numerous growth opportunities for the subcutaneous implantable defibrillator market over the coming years.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of subcutaneous implantable defibrillator is evaluated at USD 9.36 billion.
Subcutaneous Implantable Defibrillator Market size was valued at USD 9.02 billion in 2024 and is set to exceed USD 15.79 billion by 2037, registering over 4.4% CAGR during the forecast period i.e., between 2025-2037.
North America industry is estimated to dominate majority revenue share by 2037, led by rising geriatric population, and availability of advanced treatment options in the region.
The major players in the market are Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, Inc., MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., and St. Jude Medical, Inc., and others.
